furthermore , physostigmine-glycopyrrolate reversal of midazolam-induced sedation was associated with nausea ( five subjects ) , vomiting ( three subjects ) , and tachycardia without reversal of the depressed hypoxic ventilatory response .
C0017970
glycopyrrolate
C0039231
tachycardia